Citigroup Has Lowered Expectations for Ardelyx (NASDAQ:ARDX) Stock Price
Ardelyx (NASDAQ:ARDX – Get Free Report) had its price target dropped by equities research analysts at Citigroup from $11.00 to $10.00 in a research note issued on Friday,Benzinga reports. The brokerage currently has a “buy” rating on the biopharmaceutical company’s stock. Citigroup’s target price points to a potential upside of 142.13% from the stock’s previous […]
